Fifteen controlled trials (47,682 women) were included.
The mean proportion of women achieving a successful vaginal birth was 72.3% (95% CI: 71.8, 72.8).
Uterine rupture (11 controlled trials, 39,116 women).
The rupture rates were significantly increased in women undergoing trial of labour than in those undergoing elective Caesarean delivery; the OR was 2.10 (95% CI: 1.45, 3.05). The rates were also significantly increased after pooling 5 prospective cohort trials (OR 2.06, 95% CI: 1.40, 3.04), but not after pooling the 6 retrospective cohort studies.
Maternal mortality (8 controlled trials, 45,244 women).
There were 3 maternal deaths among 27,504 women undergoing trial of labour, and no maternal deaths among 17,740 women undergoing repeat Caesarean delivery. All 3 deaths were in women undergoing Caesarean section after a trial of labour: 2 resulted from thromboembolic complications, whilst the other occurred after aspiration of gastric contents on anaesthesia. There was no statistically significant difference between the intervention groups, either for all studies combined (OR 1.52, 95% CI: 0.36, 6.38), or for separate analyses of prospective and retrospective studies.
Neonatal mortality (11 controlled trials, 39,525 women).
The rates were significantly increased in women undergoing trial of labour, compared with elective Caesarean delivery; the OR was 1.71 (95% CI: 1.28, 2.28). The rates were also significantly increased after pooling 6 prospective cohort trials (OR 1.75, 95% CI: 1.30, 2.34), but not after pooling the 5 retrospective cohort studies. The analysis was repeated after excluding those perinatal deaths attributable to intra-uterine death before onset of labour, lethal anomalies, and prematurity (9 controlled trials). The results showed that neonatal mortality remained significantly increased in women undergoing trial of labour, compared with elective Caesarean delivery; the OR was 2.05 (95% CI: 1.17, 3.57).
Five-minute Apgar score less than 7 (7 controlled trials, 3,313 women).
The rates were significantly increased in women undergoing trial of labour, compared with elective Caesarean delivery; the OR was 2.24 (95% CI: 1.29, 3.88). The rates were also significantly increased after pooling 2 prospective cohort trials (OR 2.27, 95% CI: 1.16, 4.71), but not after pooling the 5 retrospective cohort studies.
Maternal febrile morbidity (9 controlled trial, 45,061 women).
The rates were significantly decreased in women undergoing trial of labour, compared with elective Caesarean delivery; the OR was 0.70 (95% CI: 0.64, 0.77). The results were consistent across all studies.
Hysterectomy (6 controlled trials, 44,123 women).
The rates were significantly decreased in women undergoing trial of labour, compared with elective Caesarean delivery; the OR was 0.39 (95% CI: 0.27, 0.57). The results were consistent across all 5 prospective studies (OR 0.38, 95% CI: 0.26, 0.56).
High-quality studies (6 controlled trials).
For all outcomes other than the 5-minute Apgar scores (only 1 trial), the subgroup analysis confirmed the results of the total analyses.
The authors reported that their review had several limitations: there was a lack of information regarding long-term neurologic outcomes among children; there was an absence of data to allow controlling for prematurity in determining the Apgar outcome; all the data came from non-randomised studies, thus limiting the evidence.